1 in 8 US adults have tried a GLP-1 treatment. As usage grows, consumers are seeking ways to manage related concerns like digestive issues and muscle mass loss.
By affecting appetite and gastric emptying, GLP-1 therapies change eating habits—often resulting in smaller portions and reduced food intake. This makes nutritional quality especially important, with users needing adequate protein and fiber to support muscle maintenance, digestion, and satiety.
Discover how Roquette’s plant-based solutions can support your next product development project.
Download our white paper.





